Effect of Plasma Ceramides on Peripheral Vascular Function
NCT05107869 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23
Last updated 2025-06-29
Summary
The goal of this clinical trial is to determine the effect of elevated plasma ceramides on peripheral vascular function. Subjects will consume a high fat meal consisting of long chain fatty acids (to increase plasma ceramides) or medium chain fatty acids (control). Subjects' vascular function will be assessed with laser Doppler flowmetry to measure their artery function and with the CytoCam device to assess their peripheral microvascular endothelial function.
Conditions
- Peripheral Vascular Disease
- Lipid Disorder
- Endothelial Dysfunction
Interventions
- OTHER
-
High Saturated Fat
High saturated fat meal
Sponsors & Collaborators
-
Medical College of Wisconsin
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-05-01
- Primary Completion
- 2025-05-07
- Completion
- 2025-05-07
Countries
- United States
Study Locations
More Related Trials
-
THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.
NCT02381769 ·Status: COMPLETED ·Phase: NA
-
Selenium Supplementation of Patients With Cirrhosis
NCT00212212 ·Status: TERMINATED ·Phase: NA
-
Study of Aldafermin (NGM282) in Participants With Impaired Hepatic Function
NCT04823702 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects
NCT00983788 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Conjugated Linoleic Acid Intake on Liver and Kidney Function
NCT00449462 ·Status: COMPLETED ·Phase: NA
-
FBCx (Alpha-CD) Mechanism of Action Trial
NCT02999620 ·Status: COMPLETED ·Phase: NA
-
Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
NCT04227678 ·Status: RECRUITING ·Phase: NA
-
Intramuscular Diclofenac in the Prevention of Post-ERCP Pancreatitis
NCT01717599 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis
NCT00004346 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD
NCT05897606 ·Status: COMPLETED ·Phase: PHASE1
-
Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression
NCT05291104 ·Status: COMPLETED ·Phase: NA
-
Selenium Supplementation of Patients With Cirrhosis
NCT00212186 ·Status: COMPLETED ·Phase: NA
-
Intralumenal Effects on Cholesterol Absorption/Synthesis
NCT00328211 ·Status: COMPLETED ·Phase: NA
-
Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus
NCT02871882 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding
NCT05112328 ·Status: RECRUITING ·Phase: NA
-
Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M
NCT02830763 ·Status: TERMINATED ·Phase: NA
-
Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome
NCT00004347 ·Status: UNKNOWN ·Phase: PHASE2
-
Plasma Dihydroceramides Are Associated With Hepatic Steatosis in Type 1 and Type 2 Diabetes
NCT03447964 ·Status: COMPLETED
-
Effects of Emulsification and Lipid Droplet Size on Postprandial Metabolic Responses
NCT02789683 ·Status: COMPLETED ·Phase: NA
-
Application of n-3 Fatty to Patient of Jaundice
NCT03376945 ·Status: COMPLETED
-
Gastric Emptying and Gallbladder Motility Study
NCT00940849 ·Status: COMPLETED ·Phase: NA
-
A Multi-center Evaluation of Aldafermin in a Randomized, Double-blind, Placebo-controlled Study in Subjects With Primary Sclerosing Cholangitis.
NCT06654726 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease
NCT01016418 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Nutritional Therapy of the Deficits of Oxidation Mitochondrial of the Fatty Acids
NCT00328159 ·Status: COMPLETED ·Phase: NA
-
A Study of Chenodeoxycholic Acid (CDCA) in Newly Diagnosed Participants With Cerebrotendinous Xanthomatosis (CTX)
NCT06260748 ·Status: WITHDRAWN ·Phase: PHASE3